FI962976A - Kompositioner för behandling av galukom innehållande pilokarpin och beta-spärrare - Google Patents

Kompositioner för behandling av galukom innehållande pilokarpin och beta-spärrare Download PDF

Info

Publication number
FI962976A
FI962976A FI962976A FI962976A FI962976A FI 962976 A FI962976 A FI 962976A FI 962976 A FI962976 A FI 962976A FI 962976 A FI962976 A FI 962976A FI 962976 A FI962976 A FI 962976A
Authority
FI
Finland
Prior art keywords
blocker
beta
compositions
treatment
cataracts
Prior art date
Application number
FI962976A
Other languages
English (en)
Finnish (fi)
Other versions
FI962976A0 (sv
Inventor
Yusuf Ali
Rajni Jani
George R Mccarty
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of FI962976A publication Critical patent/FI962976A/sv
Publication of FI962976A0 publication Critical patent/FI962976A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI962976A 1994-01-28 1996-07-26 Kompositioner för behandling av galukom innehållande pilokarpin och beta-spärrare FI962976A0 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18828494A 1994-01-28 1994-01-28
US08/334,512 US5554367A (en) 1984-10-31 1994-11-04 Compositions for treatment of glaucoma
PCT/US1995/001017 WO1995020378A1 (en) 1994-01-28 1995-01-24 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker

Publications (2)

Publication Number Publication Date
FI962976A true FI962976A (sv) 1996-07-26
FI962976A0 FI962976A0 (sv) 1996-07-26

Family

ID=26883909

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962976A FI962976A0 (sv) 1994-01-28 1996-07-26 Kompositioner för behandling av galukom innehållande pilokarpin och beta-spärrare

Country Status (9)

Country Link
US (1) US5554367A (sv)
EP (1) EP0741563A1 (sv)
JP (1) JP2854418B2 (sv)
AU (1) AU688854B2 (sv)
CA (1) CA2181929C (sv)
FI (1) FI962976A0 (sv)
MX (1) MX9603060A (sv)
NO (1) NO963130L (sv)
WO (1) WO1995020378A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022715A1 (en) * 1997-11-05 1999-05-14 Senju Pharmaceutical Co., Ltd. Sustained release eyedrops
US6335335B2 (en) 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
US6211238B1 (en) * 1998-10-27 2001-04-03 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
TR200302008T4 (tr) * 1999-11-30 2004-01-21 Alcon, Inc. Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
US20050147584A1 (en) * 2004-01-05 2005-07-07 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US20050031652A1 (en) * 2003-02-25 2005-02-10 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US20050106321A1 (en) * 2003-11-14 2005-05-19 Molecular Imprints, Inc. Dispense geometery to achieve high-speed filling and throughput
US20050277698A1 (en) * 2004-01-05 2005-12-15 Hughes Patrick M Memantine delivery to the back of the eye
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
JP5576659B2 (ja) * 2006-12-05 2014-08-20 ザ ロイヤル インスティテューション フォー ジ アドバンスメント オブ ラーニング／ マギル ユニバーシティ Ｔｒｋレセプター調節因子の使用方法
PT2572717T (pt) * 2010-05-19 2016-07-19 Astellas Pharma Inc Composição farmacêutica contendo solifenacina
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2330383A1 (fr) * 1975-11-06 1977-06-03 Synthelabo Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment
US4342783A (en) * 1980-06-30 1982-08-03 Synthelabo Anti-glaucoma agent
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2601247A1 (fr) * 1986-07-09 1988-01-15 Merk Sharp Dohme Chibret Labor Combinaison d'agents beta-bloquants et de pilocarpine.
US5182102A (en) * 1991-07-12 1993-01-26 Alcon Laboratories, Inc. Anti-glaucoma compositions
AU666957B2 (en) * 1992-08-28 1996-02-29 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions

Also Published As

Publication number Publication date
FI962976A0 (sv) 1996-07-26
NO963130D0 (no) 1996-07-26
EP0741563A1 (en) 1996-11-13
WO1995020378A1 (en) 1995-08-03
US5554367A (en) 1996-09-10
MX9603060A (es) 1997-03-29
JP2854418B2 (ja) 1999-02-03
JPH09505604A (ja) 1997-06-03
CA2181929A1 (en) 1995-08-03
AU688854B2 (en) 1998-03-19
AU1607495A (en) 1995-08-15
CA2181929C (en) 1998-11-03
NO963130L (no) 1996-07-26

Similar Documents

Publication Publication Date Title
DE19581637T1 (de) Multifunktionelle, biologisch dispergierende/biozide Zusammensetzungen
PT775126E (pt) 1,1-dioxidos de 1,4-benzotiazepina hipolipidemica
DK0799297T3 (da) Fortykkede persyresammensætninger
CY2004003I2 (el) Παραγωγα 2-(2-αμινο-1, 6-διϋδρο-6-οξο-πυρινο-9-υλο)-μεθοδυ-1,3-προπανεδιολης
DK0799298T3 (da) Fortykkede persyresammensætninger
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
FI962976A (sv) Kompositioner för behandling av galukom innehållande pilokarpin och beta-spärrare
FI971674A0 (sv) Di-tert-butylfenolföreningar med en heterocyklisk grupp användbara som antiinflammatoriska medel
TR199501653A2 (tr) Silikonlu bilesimler.
FI941776A0 (sv) Förfarande för framställning av 1,2,4-tiadiazoler
IS4321A (is) Nýjar díalkoxý-pýridínýl-bensimidasólafleiður
FI970151A (sv) Antivirusverkande difluorstatonföreningar
FI973644A0 (sv) Nytt förfarande för framställning av 2,3-dihydrobenzofuranolderivat
TR199501652A2 (tr) Silikonlu bilesimler.
KR960702835A (ko) 헤테로사이클릭 화학(Heterocyclic chemistry)
FI972624A0 (sv) 19-norprogesteronderivat innehållande en 14alfa,17alfa-C2-brygga
TR199501647A2 (tr) Silikonlu bilesimler.
TR28915A (tr) Naftokinon türevleri.
FI972694A (sv) Nytt förfarande för framställning av sameridin
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
DE9419898U1 (de) Zündholzschachtel
SE9402838D0 (sv) New compounds
SE9403728D0 (sv) New compounds